Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis

Author:

Dykes Kaitlyn C.12ORCID,Chou Jiling3,Taylor Allison O.4ORCID,Shu Albert C.1,Mudra Sarah E.1,Ma Xiaoyang3,Ahn Jaeil3,Lai Catherine E.56ORCID

Affiliation:

1. Department of Medicine MedStar Georgetown University Hospital Washington DC USA

2. Department of Medicine, Division of Hematology and Oncology University of California San Diego Moores Cancer Center San Diego California USA

3. Department of Biostatistics, Bioinformatics and Biomathematics Georgetown University Washington DC USA

4. Department of Medicine, Division of Hematologic Malignancies & Cellular Therapy Duke Cancer Institute Durham North Carolina USA

5. Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital Washington DC USA

6. Perelman‐University of Pennsylvania Hospital Philadelphia Pennsylvania USA

Abstract

ABSTRACTBakgroundIt is important to understand the outcomes of adult acute lymphoblastic leukemia (ALL) patients at different facilities as treatment paradigms change.AimsOur primary objective was to determine adult ALL overall survival (OS) by facility volume and type. Secondary objectives included identifying sociodemographic factors that may have impacted outcomes and analyzing treatment patterns by facility volume and type.MethodsThis was a retrospective analysis of the National Cancer Database (NCDB) that included patients ≥40 years diagnosed with ALL between 2004 and 2016.ResultsA total of 14 593 patients were included in this study. Univariate OS was greatest at low volume (LV) and community programs (CPs) and the least at high volume (HV) and academic programs (AP). This difference was lost after multivariable Cox proportional hazards model analysis, which found no difference in survival by facility volume or type, however, survival was significantly influenced by age, race, Hispanic ethnicity, insurance, and residence location (p < 0.05). Patients treated at HV and APs compared to LV and CP received more anti‐neoplastic directed therapy.ConclusionOur results suggest treatment facility volume and type do not impact older adult ALL patient (≥40 years) survival, however confounding sociodemographic differences do impact survival outcomes, despite more aggressive and novel treatment approaches provided at HV and APs.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3